Clinical Trial

Evaluation of Central Sensitization, Fear-Avoidance, and Pain-Pressure Threshold With Chronic Pain After Hysterectomy

Study acronym: EPOCH
Recruiting
View on ClinicalTrials.gov →
Summary
Phase 1 (started in July 2019): Central Sensitization Inventory (CSI), Fear-Avoidance Components Scale (FACS), pain-pressure threshold are factors associated with chronic post-hysterectomy pain (CPHP), but a complete understanding on the development of CPHP is lacking. The study aims to identify clinically-relevant factors for CPHP that can be reliably assessed preoperatively. === Phase 2 (anticipated start May 2022): In addition to above factors, the association between heart rate variability (HRV) parameters, anxiety level, anticipated pain, and anticipated analgesia requirement with significant postoperative pain and CPHP will be investigated.
Protocol Amendment History 1 change
notable Primary completion pushed: 2025-12 -> 2027-12 2026-08-15
Trial Details
NCT Number NCT04014829
Lead Sponsor KK Women's and Children's Hospital
Conditions Hysterectomy, Chronic Pain, Central Sensitisation, Anxiety Depression
Enrollment 436 participants
Start Date 2019-07-23
Primary Completion 2027-12 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2026-08-14